WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids managing early-stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support. Our schedule over the previous month was filled with ongoing and new projects for multiple clients  as operations continue with appropriate safety measures for the health of our emplo...

WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids. We increase efficiency ‘from lab to launch’ managing early-stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support. WDPRX PLANS MANUFACTURE OF FIRST-TO-MARKET GENERIC The first-to-market formulation for a generic liquid item for Creekwood Pharmaceutic...

WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids. We increase efficiency ‘from lab to launch’ managing early stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support.   NEW EQUIPMENT ALLOWS WDPRX TO PERFORM NEW CAPABILITIES                     &nb...

WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids. We increase efficiency ‘from lab to launch’ managing early stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support.   WDPRX JOINS GROUP PROMOTING SUSTAINABLE DRUG DISPOSAL                     &nbs...

WDPrx Business Development Director Angela Holley wrote an article about serialization that appeared in the June 2019 issue of Contract Pharma magazine. The story explains circumstances faced by small and mid-size manufacturers that chose to forego the expense of upgrading their equipment to comply with DSCSA serialization requirements by the November 2018 deadline. These companies are selecting contract manufacturers with the proper capabilities to perform serialization-as-a-service functions o...